Test Price
2,800 AED✅ Home Collection Available
TSPAN7 Gene X‑Linked Intellectual Disability Type 58 Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy: 99.9% diagnostic sensitivity via ISO‑accredited NGS analysis for detecting pathogenic variants in TSPAN7.
- Premium Logistics: VIP Mobile Phlebotomy & temperature‑controlled cold‑chain home collection available daily 8 AM – 11 PM.
- Clinical Guidance: DHA‑licensed Consultant Medical Geneticist provides telephonic post‑test interpretation.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
Next‑Generation Sequencing (NGS) of the TSPAN7 gene covering all coding exons and flanking intronic regions, with copy number variant (CNV) detection. This comprehensive analysis enables precise molecular diagnosis of X‑linked intellectual disability type 58 (MRX58) and informs recurrence risk for family planning.
| Feature | Our NGS Test (TSPAN7) | Closest Alternative (Targeted Sanger) |
|---|---|---|
| Precision | Full gene sequencing with CNV detection | Limited to known point mutations; may miss structural variants |
| Methodology | NGS verified by orthogonal methods | Sanger sequencing of single exons |
| Turnaround Time | 3 to 4 Weeks | Usually 6–8 Weeks |
Physician Insight & Safety Protocols
“The TSPAN7 genetic test provides critical information for diagnosing X‑linked intellectual disability. Results must be interpreted alongside a full clinical history, pedigree analysis, and neurological evaluation. I always emphasise post‑test counselling with the patient’s care team to guide management and family planning decisions.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠️ Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. Genetic results may influence therapy decisions; always review findings with your neurologist.
Safety Exclusion Criteria & ER Red Flags
- Active bleeding disorder or severe anaemia (Hb < 7 g/dL) – postpone blood collection.
- Patient unable to provide a venous blood or FTA card sample safely.
- This test is not intended for acute neurological emergencies; seek immediate medical attention for sudden loss of consciousness, seizures, or focal deficits.
Patient FAQ & Clinical Guidance
1. What does the TSPAN7 gene test for intellectual disability detect?
Snippet: The test detects pathogenic variants in TSPAN7 causing X‑linked intellectual disability type 58, enabling precise diagnosis and recurrence risk assessment.
Full NGS sequencing identifies mutations associated with moderate‑to‑severe cognitive impairment, behavioural challenges, and seizures. Results confirm the genetic aetiology and guide neurologists in counselling families.
2. How should I prepare for the test and is genetic counselling required?
Snippet: Pre‑test genetic counselling is mandatory to construct a pedigree and review clinical history, ensuring appropriate sample collection.
You will have a counselling session to discuss family history and test implications. A small blood sample (venous or finger‑prick on FTA card) is then collected under DHA‑approved protocols. No special preparation is needed.
3. How quickly will I receive my results and how are they communicated?
Snippet: Results are reported within 3 to 4 weeks and delivered via secure portal with optional telephonic interpretation by a genetic specialist.
You receive a formal PDF report including variant classification, clinical interpretation, and recommendations. A DHA‑licensed Consultant Medical Geneticist is available to discuss findings before any medical decisions.
UAE Regulatory & Data Privacy Adherence
This genetic test is performed under the regulatory oversight of the Dubai Health Authority (DHA Facility License No. 1143). All patient data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and informed consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Specimen collection, handling, and reporting follow DHA‑mandated quality standards. Operated by DNA Labs UAE at Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | TSPAN7 Gene X‑Linked Intellectual Disability Type 58 Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood or Dried Blood Spot (FTA Card) |
| Methodology Used | Next‑Generation Sequencing (NGS) with Copy Number Variant (CNV) Detection |
| ICD-10-CM Code | F79, Q99.8 |
| LOINC Code | 83329-9 |
| DHA Facility License & Laboratory Address | License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Operated by DNA Labs UAE. |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians